AV-412
AV-412 性质
| 沸点 | 672.9±55.0 °C(Predicted) |
|---|---|
| 密度 | 1.33 |
| 储存条件 | Store at -20°C |
| 溶解度 | 二甲基亚砜:≥ 50 mg/ml(98.62 mM) |
| 酸度系数(pKa) | 11.61±0.43(Predicted) |
| 形态 | 粉末 |
| 颜色 | 白色至黄色 |
AV-412 用途与合成方法
|
EGFR 0.75 nM (IC 50 ) |
ErbB2 19 nM (IC 50 ) |
EGFR L858R 0.51 nM (IC 50 ) |
EGFR L858R/T790M 2.3 nM (IC 50 ) |
EGFR T790M 0.79 nM (IC 50 ) |
AV-412 inhibits autophosphorylation of EGFR and ErbB2 with IC 50 of 43 and 282 nM, respectively. AV-412 also inhibits epidermal growth factor (EGF)-dependent cell proliferation with an IC 50 of 100 nM. AV-412 abrogates EGFR signaling in the gefitinib-resistant H1975 cell line, which harbors a double mutation of L858R and T790M in EGFR.
In animal studies using cancer xenograft models, AV-412 (30 mg/kg) demonstrates complete inhibition of tumor growth of the A431 and BT-474 cell lines, which overexpress EGFR and ErbB2, respectively. AV-412 suppresses autophosphorylation of EGFR and ErbB2 at the dose corresponding to its antitumor efficacy. When various dosing schedules are applied, AV-412 shows significant effects with daily and every-other-day schedules, but not with a once-weekly schedule, suggesting that frequent dosing is preferable for this compound. Furthermore, AV-412 shows a significant antitumor effect on the ErbB2-overexpressing breast cancer KPL-4 cell line, which is resistant to gefitinib.
451494-30-7
79-10-7
451492-95-8
将氨基化合物2a(6.08 g,13.4 mmol)、丙烯酸(1.38 mL,20.1 mmol)、三乙胺(2.8 mL,20.1 mmol)和EDC(3.86 g,20.1 mmol)溶解于DMF(100 mL)中,室温搅拌反应过夜。随后,向反应体系中追加丙烯酸(0.46 mL,6.71 mmol)、三乙胺(0.93 mL,6.71 mmol)和EDC(1.29 g,6.71 mmol),继续搅拌反应过夜。反应完成后,将混合物倒入碳酸氢钠水溶液(300 mL)中,过滤收集沉淀。沉淀依次用水和乙醇-水混合溶剂洗涤,干燥。粗产物通过加热搅拌溶解于乙醇-水混合溶剂中,冷却至室温后过滤,收集沉淀并干燥,得到目标产物N-(4-((3-氯-4-氟苯基)氨基)-7-(3-甲基-3-(4-甲基哌嗪-1-基)丁-1-炔-1-基)喹唑啉-6-基)丙烯酰胺1a(3.41 g,收率50%)。[CHEMMOL-00368] 1a的1H NMR(DMSO-d6)δppm:1.44(s,6H),2.15(s,3H),2.35(br s,4H),2.64(br s,4H),5.85(d,J = 10.3 Hz,1H),6.33(d,J = 16.9 Hz,1H),6.58(dd,J = 10.3,16.9 Hz,1H),7.47(t,J = 9.1 Hz,1H),7.84(br s,2H),8.20(br d,J = 6.1Hz,1H),8.64(s,1H),8.69(s,1H),9.88(s,1H),10.01(s,1H)。
参考文献:
[1] Patent: US2004/116422, 2004, A1. Location in patent: Page/Page column 32-33
AV-412 价格(试剂级)
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2025-12-22 | HY-10346A | AV-412 | 451492-95-8 | 5mg | 1080 |
| 2025-12-22 | HY-10346A | AV-412 | 451492-95-8 | 10mM * 1mLin DMSO | 1200 |